SCHEMBL11305498

SCHEMBL11305498

O=C(O)c1ccc(CCNC(=O)c2cc(Cl)ccc2N2Cc3ccccc3C2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.53
▸ LMNA P02545 3/20 0.53
▸ NAMPT P43490 4/20 0.53
▸ NPC1 O15118 3/20 0.47
▸ RAB9A P51151 3/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.46
▸ TP53 P04637 1/20 0.46
▸ GAA P10253 3/20 0.45
▸ HTT P42858 1/20 0.45
▸ DNMT3A Q9Y6K1 1/20 0.44
▸ TMEM97 Q5BJF2 1/20 0.44
▸ SIGMAR1 Q99720 1/20 0.44
▸ TNKS O95271 1/20 0.44
▸ TNKS2 Q9H2K2 1/20 0.44
▸ MCHR1 Q99705 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ GFER P55789 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11197083 0.87 MAPT (0.52) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL11441498 0.86 MCHR1 (0.56) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL11165965 0.85 MCHR1 (0.55) MAPTLMNAMCHR1CYP2D6
SCHEMBL10356773 0.85 MCHR1 (0.55) MAPTLMNAMCHR1CYP2D6
SCHEMBL11165531 0.85 MCHR1 (0.55) MAPTLMNAMCHR1CYP2D6
SCHEMBL11194495 0.83 EGFR (0.53) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL11201219 0.83 MAPT (0.48) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL11178554 0.83 MAPT (0.52) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL11180080 0.83 MAPT (0.54) MAPTLMNANPC1RAB9ASMN1; SMN2
SCHEMBL11193056 0.82 MAPT (0.46) MAPTLMNANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0056144-A1 Carboxylic acid derivatives, their preparation and use as pharmaceuticals Dr. Karl Thomae GmbH (DE) 1982-07-21 — — EP disclosed
Send feedback